Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice

Translational Research

Volumn 149, Issue 2, 2007, Pages 70-75

  Martin McNulty, Baby ^a   Zhang, Lening ^b   da Cunha, Valdeci ^a   Vincelette, Jon ^a   Rutledge, John C ^b   Vergona, Ronald ^a   Sullivan, Mark E ^a   Wang, Yi Xin ^a  

^a BAYER AG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN II; UROKINASE;

ADVENTITIA; ANIMAL EXPERIMENT; ARTERY LESION; ARTERY MEDIA; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY LIGATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; INTIMA; MACROPHAGE; MORPHOLOGY; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 33846232141     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.09.002     Document Type: Article

References (34)

1. Carmeliet P., Moons L., Herbert J.M., Crawley J., Lupu F., Lijnen R., et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 81 (1997) 829-839
2. Carmeliet P., Moons L., Lijnen R., Baes M., Lemaitre V., Tipping P., et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17 (1997) 439-444
3. Schneiderman J., Bordin G.M., Adar R., Smolinsky A., Seiffert D., Engelberg I., et al. Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol 152 (1998) 703-710
4. Schneiderman J., Bordin G.M., Engelberg I., Adar R., Seiffert D., Thinnes T., et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 96 (1995) 639-645
5. Shah P.K. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96 (1997) 2115-2117
6. Plekhanova O.S., Parfyonova Y.V., Bibilashvily R., Stepanova V.V., Erne P., Bobik A., et al. Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens 18 (2000) 1065-1069
7. Hassoun P.M. Deciphering the "matrix" in pulmonary vascular remodelling. Eur Respir J 25 (2005) 778-779
8. Lepetit H., Eddahibi S., Fadel E., Frisdal E., Munaut C., Noel A., et al. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 25 (2005) 834-842
9. Li Y., Minamino T., Tsukamoto O., Yujiri T., Shintani Y., and Okada K.-i. Ablation of mek kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model. Circulation 111 (2005) 1672-1678
10. Farb A., Kolodgie F.D., Hwang J.Y., Burke A.P., Tefera K., Weber D.K., et al. Extracellular matrix changes in stented human coronary arteries. Circulation 110 (2004) 940-947
11. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
12. Waller B.F. Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease. Cardiol Clin 7 (1989) 749-770
13. Carlier S.G., van Damme L.C., Blommerde C.P., Wentzel J.J., van Langehove G., Verheye S., et al. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?. Circulation 107 (2003) 2741-2746
14. Wentzel J.J., Gijsen F.J., Stergiopulos N., Serruys P.W., Slager C.J., and Krams R. Shear stress, vascular remodeling and neointimal formation. J Biomech 36 (2003) 681-688
15. Zhang L.-N., Wilson D.W., da Cunha V., Sullivan M.E., Vergona R., Rutledge J.C., et al. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1{alpha} in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 26 (2006) 765-772
16. Deng G.G., Martin-McNulty B., Sukovich D.A., Freay A., Halks-Miller M., Thinnes T., et al. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 92 (2003) 510-517
17. Tham D.M., Martin-McNulty B., Wang Y.X., Wilson D.W., Vergona R., Sullivan M.E., et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11 (2002) 21-30
18. Wang Y.X., Martin-McNulty B., Freay A.D., Sukovich D.A., Halks-Miller M., Li W.W., et al. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159 (2001) 1455-1464
19. Zhang L.-N., da Cunha V., Martin-McNulty B., Wilson D.W., Sullivan M.E., Vergona R., et al. Endothelial nitric oxide synthase deficiency enhanced carotid artery ligation-induced remodeling by promoting vascular Inflammation. J Appl Res 6 (2006) 100-114
20. Campbell G.R., Campbell J.H., Manderson J.A., Horrigan S., and Rennick R.E. Arterial smooth muscle. A multifunctional mesenchymal cell. Arch Pathol Lab Med 112 (1988) 977-986
21. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93 (1996) 2178-2187
22. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94 (1996) 1655-1664
23. Wilcox J.N., Cipolla G.D., Martin F.H., Simonet L., Dunn B., Ross C.E., et al. Contribution of adventitial myofibroblasts to vascular remodeling and lesion formation after experimental angioplasty in pig coronary arteries. Ann NY Acad Sci 811 (1997) 437-447
24. Chung I.M., Schwartz S.M., and Murry C.E. Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am J Pathol 152 (1998) 913-923
25. Schwartz S.M., and Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49 (1998) 437-460
26. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
27. Xu Y., Arai H., Zhuge X., Sano H., Murayama T., Yoshimoto M., et al. Role of bone marrow-derived progenitor cells in cuff-induced vascular injury in mice. Arterioscler Thromb Vasc Biol 24 (2004) 477-482
28. Tkachuk V., Stepanova V., Little P.J., and Bobik A. Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol 23 (1996) 759-765
29. George S.J., Johnson J.L., Smith M.A., and Jackson C.L. Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein. J Vasc Res 38 (2001) 492-501
30. Parfyonova Y., Plekhanova O., Solomatina M., Naumov V., Bobik A., and Berk B. Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury. J Vasc Res 41 (2004) 268-276
31. Brasier A.R., Jamaluddin M., Han Y., Patterson C., and Runge M.S. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem 212 (2000) 155-169
32. Prescott M.F., Webb R.L., and Reidy M.A. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 139 (1991) 1291-1296
33. Taguchi J., Abe J., Ohno M., Schwartz S.M., and Kurokawa K. Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury. Blood Press Suppl 5 (1994) 38-42
34. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., and Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. Embo J 16 (1997) 7279-7286